Abstract
Introduction:
Sleep disturbances increase pain sensitivity in clinical and preclinical settings, but the precise mechanisms are unknown. This represents a major public health issue because of the growing sleep deficiency epidemic fueled by modern lifestyle. To understand the neural pathways at the intersection between sleep and pain processes, it is critical to determine the precise nature of the sleep disruptions that increase pain and the specific component of the pain response that is targeted.
Methods:
We performed a review of the literature about sleep disturbances and pain sensitivity in humans and rodents by taking into consideration the targeted sleep stage (REMS, non–NREMS, or both), the amount of sleep lost, and the different types of sleep disruptions (partial or total sleep loss, duration, sleep fragmentation or interruptions), and how these differences might affect distinct components of the pain response.
Results:
We find that the effects of sleep disturbances on pain are highly conserved among species. The major driver for pain hypersensitivity appears to be the total amount of sleep lost, while REMS loss by itself does not seem to have a direct effect on pain sensitivity. Sleep loss caused by extended wakefulness preferentially increases pain perception, whereas interrupted and limited sleep strongly dysregulates descending controls such as DNIC, especially in women.
Discussion:
We discuss the possible mechanisms involved, including an increase in inflammatory processes, a loss of nociceptive inhibitory pathways, and a defect in the cognitive processing of noxious input.
Introduction
When individuals do not get sufficient sleep or have their sleep curtailed, they fail to maintain normal levels of alertness, which translates into attentional lapses and poor cognitive performances (Van Dongen et al., 2003; Goel et al., 2009; McHill et al., 2018). Insufficient sleep also negatively impacts metabolism (Spiegel et al., 1999; Tasali et al., 2008), immune and cardiovascular functions (Faraut et al., 2012; Tobaldini et al., 2014; Kohansieh and Makaryus, 2015; Irwin et al., 2016), emotional regulation (Walker, 2009; Simon et al., 2015), and pain (Smith and Haythornthwaite, 2004; National Sleep Foundation, 2015). The overall enhancement in pain sensitivity caused by various sleep disturbances has been widely reported both at the clinical and preclinical levels with consistent effects across species (Lautenbacher et al., 2006; Finan et al., 2013; Schrimpf et al., 2015; Alexandre et al., ). In sharp contrast, sleep disturbances do not increase sensitivity to innocuous stimuli of various sensory modalities: thermal discrimination, responsivity to light mechanical stimuli, auditory and visual acuities are not changed by sleep loss (Kundermann et al., 2004; Franzen et al., 2009; Scherer et al., 2013; Alexandre et al., ). Altogether, these results indicate that inadequate sleep specifically enhances pain sensitivity, but the precise mechanisms responsible remain largely unknown.
Pain is a complex neural process that involve detecting a potentially harmful stimulus via specialized peripheral sensory neurons called nociceptors, integrating the information at the spinal cord level before sending it to the brain where a pain sensation is generated to incorporate sensory-discriminative, emotional, limbic and even cognitive components (Figure 1A). Virtually all the components of the pain response can be modulated along the nociceptive and pain pathways to either enhance or depress the pain signal (Figure 1A). The ultimate pain sensation generated is the result of the integration of all these pain components, which contributes to the multifactorial and individualized features of pain. Therefore, an overall increase in pain sensitivity can be obtained by various mechanisms, raising the possibility that different sleep disturbances alter pain processing at distinct levels of the nociceptive and pain pathways, and thus could have cumulative effects.
Figure 1
Sleep is also a complex and dynamic neural process that comprises of two major and distinct states, rapid eye movement (REM) sleep and non–rapid eye movement (NREM) sleep. They alternate periodically throughout the sleep cycle and can be distinguished based on their electroencephalogram (EEG) and electromyogram (EMG) features (Aserinsky and Kleitman, ). In normal conditions, sleep architecture has a predictable macro-organization with NREMS always preceding REMS (Figure 1B). In humans, three stages of NREMS have been characterized based on their EEG features and to reflect transition into “deeper” sleep (N1, N2, and N3 which is also designated as slow wave sleep SWS). NREMS intensity can be assessed by quantifying the EEG power between 0.5 and 4 Hz, also known as slow-wave activity (SWA) (Borbely, ; Borbely and Achermann, ). REMS is characterized by an “activated” EEG (high frequency, low amplitude waves), no postural muscular activity on the EMG (atonia), and ocular saccades (that can be quantified with electrooculogram) in both humans and rodents. The distribution and amount of NREMS and REMS are mostly determined by two principal and interacting systems: the endogenous circadian clock and a homeostatic component that regulates the need and intensity of sleep according to the sleep-wake history (i.e., the time previously spent asleep or awake) (Borbely, ). Due to these dynamic interrelations between sleep-wake stages, many experimental sleep disruptions are poised to have broader effects on other sleep parameters than originally anticipated, notably NREMS and REMS amount. As a result, the exact effects of various sleep disturbances, especially during chronic settings, on pain processing are not clear.
To understand the neural pathways at the intersection between sleep and pain processes, it is then critical to define precisely which sleep stages (REMS, non–NREMS, or both) and what type of the sleep disruptions (sleep loss, sleep fragmentation or sleep interruptions) affect the pain sensation.
Here, we performed a review of the literature about sleep disturbances and pain sensitivity in humans and rodents by taking into consideration the amount of sleep lost. We find that NREMS loss could be the major driver for pain hypersensitivity, and that the temporal nature of the sleep disruptions could affect different components of the pain response. We then discuss possible neural mechanisms responsible and cellular pathways involved.
Part 1: Total (NREMS+REMS) sleep loss on pain
In humans, a single night of total sleep deprivation caused a decrease in pain thresholds from a heat source (8 studies out of 11), mechanical stimulus (both punctate and pressure; 5 studies out of 6) and cold (5 studies out of 6) when tested immediately at the end of the sleep deprivation (Figure 2). Furthermore, the pain response to a sustained noxious stimulus (ischemia pain, cold pressor pain) was heightened in half of the studies, suggesting a less robust or a ceiling effect of the pain response (Drewes et al., 1997; Onen et al., 2001; Larson and Carter, 2016; Eichhorn et al., 2018; Staffe et al., 2019). Spontaneous pain complaints (general body pain, low back pain, or headache) and migraine crises are more often reported after one night of total sleep deprivation (Busch et al., ; Houle et al., 2012; Palma et al., 2013). Both women and men show an hyperalgesic effect of sleep loss, with a stronger trend for women (Eichhorn et al., 2018; Staffe et al., 2019). One night of total sleep deprivation increased temporal summation of pain ratings upon repeated noxious pressure stimulations (Staffe et al., 2019), suggesting a possible spinal nociceptive facilitation (Bosma et al., ), although amplification within the brainstem, thalamus, or cortical areas might also contribute. In contrast, detection of innocuous stimuli (gentle touch, warmth) was not affected by sleep loss (Kundermann et al., 2004, 2008; Lautenbacher et al., 2006; Schuh-Hofer et al., 2013). Other sensory systems such as visual performance and acoustic startle/reactivity, showed a decrease in responsiveness after sleep loss (Franzen et al., 2009; Jung et al., 2011; Liberalesso et al., 2012; Scherer et al., 2013).
Figure 2
In rodents, acute total sleep deprivation is usually performed by variations of the gentle handling paradigm (Tobler et al., 1997; Page et al., 2014; Vanini et al., 2014; Vanini, 2016; Alexandre et al., ) with animals tested at the end of the session. Protocols providing novel objects without touching the animals are minimally stressful, allowing for an extension of wakefulness without forced locomotor activity. Nine and twelve hours of sleep deprivation caused an increased sensitivity for noxious heat (hotplate set at 52 C, radiant heat with Hargreaves), pressure (von Frey filaments) and sustained pain (capsaicin), with an overall trend toward higher responses in females (Page et al., 2014; Vanini et al., 2014; Vanini, 2016; Alexandre et al., ; Hambrecht-Wiedbusch et al., 2017). Responses to noxious cold (~4 C; acetone test) were not changed by sleep loss, in contrast to human data, which might be due to technical differences to generate cold (Harvey et al., 2010; Alexandre et al., ). Responses to somatic innocuous stimuli (gentle touch with a brush, warmth (20–37 C) detection though a thermal gradient) were not changed, even after 12 h of sleep deprivation (Alexandre et al., ). Startle responses following loud acoustic stimuli were decreased after 9 h of sleep loss (Alexandre et al., ), similar to humans and presumably reflecting fatigue. Overall, these results indicate that the enhancement of pain responses by total sleep loss is consistent and well preserved in both rodents and humans.
Part 2: State-specific sleep deprivation in humans
In humans, SWS (NREMS N3) can be interrupted by monitoring the EEG/EMG signals and applying a short auditory stimulus (80–110 dB) based on the EEG/EMG features observed in real time [for N3 = detection of slow-waves (0.5–3.5 Hz)]. This protocol does not cause a total loss of NREMS or REMS, but it increases the time spent in N1 and N2 (Arima et al., ). Three consecutive nights of SWS deprivation did not affect pressure pain responses applied to jaw muscles (Arima et al., ), while pain sensitivity to pressure at tender points (commonly used to diagnose fibromyalgia) was reported increased in some studies (Moldofsky et al., 1975; Moldofsky and Scarisbrick, 1976; Lentz et al., 1999) but not in others (Older et al., 1998). All these studies had a relatively low N (ranging from 6 to 19) which could explain the variability and possibly insufficient statistical power. No major differences on pain sensitivity were found between men and women. There is currently no specific SWS-deprivation protocol in rodents.
REMS can be interrupted in humans by a frank awakening (e.g., touching or moving subject) based on EEG/EOG/EMG features observed in real-time. Quantifying the total amount of sleep under these protocols indicates that some REMS deprivation protocols might also cause a significant loss of NREMS (~30%; Roehrs et al., 2006), while others do not (Moldofsky and Scarisbrick, 1976; Azevedo et al., ). Interestingly, REMS deprivation protocols that are not associated with total sleep loss do not increase pain even after 4 consecutive days (Azevedo et al., ), while a protocol that reduced total sleep amount increased heat pain sensitivity after a single night (Roehrs et al., 2006) (Figure 3). REMS deprivation by administration of clonidine did not change heat pain sensitivity (nor total sleep amount) in either men or women (Chouchou et al., 2015).
Figure 3
State-specific sleep deprivation in rodents
In rodents, the majority of REMS sleep deprivation has been performed using variations of the “platform-over-water” method (Mendelson et al., 1974) that take advantage of the muscle atonia occurring during REMS (Jouvet et al., 1964). Rats or mice are placed on top of a small platform surrounded by water in which they fall when they enter REMS and lose postural tone, causing them to wake up (Figure 4A). A modification of this paradigm was introduced to circumvent isolation and movement restriction by allowing a socially stable group of animals to be sleep-deprived together in a large tank containing multiple small platforms (Coenen and Van Luijtelaar, 1985). While 6 h of this paradigm does not change heat and mechanical pain sensitivity and 24 h has limited effects (Onen et al., 2000; Wei et al., 2007; Wang et al., 2015; Tomim et al., 2016; Nasehi et al., 2018; Sardi et al., 2018b), two or more consecutive days are systematically associated with an increase in pain responses for mild (44–46 C) (Onen et al., 2000; May et al., 2005; Damasceno et al., 2009; Harvey et al., 2010; Skinner et al., 2011) and intense (52 C) (Nascimento et al., 2007; Damasceno et al., 2009; Araujo et al., ; Gurel et al., 2014) heat, pressure (Randall and Selitto) (Ukponmwan et al., 1984; Onen et al., 2000; Tomim et al., 2016) and punctate (von Frey filaments) (Wei et al., 2008, 2010; Damasceno et al., 2009) mechanical stimuli, and chemical pain (Figure 4A) (Hicks et al., 1979; Onen et al., 2000; Tomim et al., 2016). The development of heat hyperalgesia is stronger in females (Araujo et al., ). However, “platform-over-water” protocols significantly reduce NREMS by ~30–50%, nearly ~4–6 h sleep loss per day (Grahnstedt and Ursin, 1985; Machado et al., 2004), making it difficult to distinguish the relative contribution of REMS or NREMS loss to the development of hyperalgesia. Interestingly, the overall onset of hyperalgesia during “platform-over-water” protocols ranges between 24 and 48 h, (corresponding to ~5–10 h total sleep loss), which is very similar to that of an acute total sleep deprivation (between 6 and 9 h) (Alexandre et al., ).
Figure 4
Sleep disruption protocols aiming at fragmenting NREMS can also indirectly prevent the transition from NREMS to REMS, thereby reducing REMS amount without significantly altering NREMS amount in most cases (Figure 4B). These protocols usually involve circular cages equipped with a rotating sweeping bar or cage floor programmed to rotate/move at specific intervals and durations (Figure 4B) (Ringgold et al., 2013; Sutton and Opp, 2014; Alexandre et al., ). Under these protocols, loss of REMS (ranging from 50 to 95%) without concomitant loss of total sleep did not alter mechanical or heat pain after one or up to 5 consecutive days in males or females (Sutton and Opp, 2014; Wodarski et al., 2015; Alexandre et al., ). In one study (Wodarski et al., 2015), 8 h of sleep fragmentation that caused a minor total sleep loss (~30%; 2 h 40 min) did not increase heat and mechanical pain responses, while a sleep fragmentation protocol that also caused ~60% total sleep loss (~5 h 30 min) increased pain responses. Such estimation of the amount of total sleep loss required to increase pain sensitivity is aligned with total sleep deprivation studies (Page et al., 2014; Alexandre et al., ).
Overall, these results suggest that traditional “REM sleep-specific” deprivation protocols relying on platforms-over-the-water techniques cause a significant total sleep loss over time, which might be the main driver for pain hypersensitivity, rather than the specific loss of REMS. Indeed, when ranking all studies that used the same pain assay (latency to withdraw on a hotplate set a 50–52 C; to mitigate technical variability) by pain intensity, we found that the main factor associated with the gradual increase in heat pain was the overall amount of sleep loss, irrespective of the sleep disruption protocol or species used (Figure 4B). Furthermore, these compiled studies suggest that when subjected to ~6 h total sleep loss per day, animals develop heat hyperalgesia with a relatively linear increase of ~7% per day and reach a plateau after 4 d (Figure 4B). There were not enough studies carried out with females to perform this analysis. The overall pain profile from acute and chronic sleep loss experiments suggests females develop stronger hyperalgesia and might reach a plateau sooner compared to males. Altogether, these results fit with the hypothesis that the amount of total sleep loss, and not REMS or sleep continuity, is the major factor associated with the increased pain sensation for heat and mechanical stimuli.
Part 3: Dynamics of sleep loss on pain
While the amount of total sleep loss appears to be a major contributor to the increased pain response, the dynamics of the sleep loss could target different components of pain processing. This can be evidenced when comparing two models of sleep disruption in humans achieving the same sleep deficit after a single night: delayed bedtime and forced awakening (Smith et al., 2007). In the delayed bedtime protocol, subjects stay awake for 4 h past their usual bedtime, while under the forced awakening protocol, subjects are awakened for 20 min every hour, and for a full hour at a random time during the night. Both protocols reduce total sleep amount by ~45–50% (~4 h). While the delayed bedtime protocol initially extends wakefulness then allows for a consolidated sleep (i.e., with increased SWS during the remaining sleep opportunity), the forced awakenings protocol interrupts sleep with transient, short (20 min to 1 h) wake periods (causing more N1 at the expense of SWS) (Figure 5). These different dynamics of sleep loss are associated with preferential changes in pain responses, possibly underlying specific mechanisms. In both men and women, a single 4-h delayed bedtime is sufficient to increase heat and mechanical pain sensitivity when subjects are tested at wake up (Roehrs et al., 2006; Tiede et al., 2010; Faraut et al., 2015; Matre et al., 2015), similar to the effects of a night of total sleep deprivation, while a single night of forced awakenings does not affect these modalities (Smith et al., 2007; Finan et al., 2017; Iacovides et al., 2017; Letzen et al., 2020). Both delayed bed onset and total sleep deprivation are associated with an extended wake, suggesting that heat and mechanical pain might be caused by a common mechanism sensitive to excessive wakefulness, i.e., a maximum period beyond which normal pain perception and neurobehavioral functioning cannot be maintained (Van Dongen et al., 2003). In support of this, administration of caffeine and modafinil, two drugs that can restore alertness, normalize heat and mechanical pain sensitivity (Vanini, 2016; Alexandre et al., ), without removing the sleep debt. Both sleepiness and pain hypersensitivity accumulate during experimental sleep deprivation (Alexandre et al., ), and sleepiness ratings in healthy individuals correlate with their pain complaints (Smith et al., 2007). Chemogenetic activation of GABAergic neurons in the anterior cingulate cortex in mice is sufficient to concomitantly increase delta power (which could indicate increased sleep pressure) and mechanical pain (Li et al., 2020). These results suggest that the neural circuits driving sleepiness could also be responsible for the heightened heat and mechanical pain sensitivity after an acute sleep loss.
Figure 5
Another major difference in pain processing between reduced yet consolidated sleep and fragmented sleep concerns diffuse noxious inhibitory controls (DNIC), a type of descending controls that can suppress the nociceptive signal at the spinal cord level. DNIC are triggered when two noxious stimulations occur simultaneously in different dermatomes, and they can be assessed in humans by using “conditioned pain modulation (CPM)” protocols (Yarnitsky, 2010; Yarnitsky et al., 2015). One night of forced awakenings strongly disrupts CPM in women (Smith et al., 2007), whereas a single 4-h delayed bedtime does not (Matre et al., 2016; 14 women, 8 men; Smith et al., 2007; women only; Matre et al., 2017; night shifts: 41 women, 12 men) (Figure 5), indicating that a mild sleep loss with disrupted continuity specifically targets these descending controls. Clinical studies support this assertion as DNICs are strongly altered in fibromyalgia patients who also suffer from mild total sleep loss and sleep disruption by awakenings (lasting more than 3 min; Lautenbacher and Rollman, 1997; Diaz-Piedra et al., 2015; Bjurstrom and Irwin, ), as well as patients with temporomandibular joint pain where DNICs were most altered in patients with poor sleep quality (Edwards et al., 2009). Interestingly, experimental sleep disturbances only disrupt DNIC in women (Eichhorn et al., 2018), which could contribute to the strong incidence of fibromyalgia and temporomandibular joint disorder pain in women.
DNICs are triggered specifically by the activation of lamina V spinal neurons (Villanueva and Le Bars, 1995) that project to the subnucleus reticularis dorsalis (SRD, also known as dorsal reticular nucleus DRt, and called medullary reticular nucleus in mice; Villanueva and Le Bars, 1995; Le Bars, 2002). Some SRD neurons project directly back into the deep dorsal horn lamina (V-VII; Villanueva et al., 1995) while others activate several medullar pathways (Bouhassira et al., ) that will also eventually project back to the spinal cord to inhibit projecting neurons (Leite-Almeida et al., 2006). It is important to note that DNICs are physiologically distinct from “traditional” descending inhibitory controls that originate from the rostroventral medulla (RVM), notably the locus coeruleus (LC) and the median raphe nucleus (MRN) (Basbaum and Fields, , ; Bouhassira et al., ; Le Bars et al., 1992; Kucharczyk et al., 2022), and the effects of forced awakenings on those are not known. Nonetheless, because delayed bed onset does not disrupt DNICs, this raises the possibility that a mild sleep loss coupled with sleep interruptions caused by the forced awakening protocol might affect more strongly lamina V pain pathways.
In contrast to heat and mechanical pain, cold pain responses are not changed by delayed bed protocol (Faraut et al., 2015), but they are increased after forced awakenings (Rosseland et al., 2018) (Figure 5).
Part 4: Chronic sleep disruptions and recovery sleep
The similar increase in acute pain responses to heat and mechanical stimuli observed after a single night of total sleep deprivation or at wake time after a delayed bedtime indicates that a short sleep opportunity is not sufficient to restore normal pain sensitivity. Indeed, the increase in heat and mechanical pain caused by sleep loss persists in humans (Roehrs et al., 2006; Tiede et al., 2010; Faraut et al., 2015; Matre et al., 2015, 2016; Odegard et al., 2015; Staffe et al., 2019) and even aggravates in rodents (Page et al., 2014; Alexandre et al., ; Sardi et al., 2018a). Cumulative deficits after sleep loss have also been reported for diverse biological processes, such as cognitive performance (Van Dongen et al., 2003; Banks et al., ), energetic metabolism (Spiegel et al., 1999; Van Cauter et al., 2008; Everson and Szabo, 2011), and immune system functions (Bryant et al., ). This is particularly relevant, because chronic insufficient sleep is becoming more frequent in the general population (up to 30%) and can be caused by poor sleep hygiene (TV, screens, etc.), work conditions (schedules/shiftwork, multiple jobs) or diseases (e.g., obesity-related sleep disorders; Holingue et al., 2018; Freire et al., 2022).
We quantified the cumulative wake amount over 5 consecutive days of experimental sleep restriction (6 h of sleep deprivation daily, starting at light onset) in mice and confirmed that despite a normal homeostatic sleep response (increased in NREMS SWA and NREMS amount) occurring each day during the sleep opportunity period, there was an accumulation of sleep loss/deficit over time (Alexandre et al., ). We compared the degree of heat hyperalgesia caused by an acute, extended wakefulness of 6, 9, and 12 h with the effects of the repeated sleep restriction protocol (6 h of extended wake per day) and found they both gradually increased, with a plateau after 12 h acute sleep deprivation or 4 d of sleep restriction (Figure 6A). Interestingly, we found that the development of heat hyperalgesia fits best when incorporating the carryover amount of wake (i.e., the sleep debt at the beginning of the active period, in blue) with the extended wake (in red, Figure 6B), rather than the relative cumulative sleep loss measured at the time of testing (i.e., at the end of the sleep deprivation session; in pink; Figure 6C).
Figure 6
Overall, the cumulative effects of sleep debt on pain could explain why heat and mechanical pain hypersensitivity takes several days to develop in complex chronic settings that are associated with a moderate total sleep loss in humans. For example, the forced awakenings protocol, which causes a 4 h total sleep loss per day, is insufficient to increase heat or mechanical (pinprick) pain after a single night (see Figure 5), but increases pain responses to both modalities after two consecutive nights (Smith et al., 2007; Iacovides et al., 2017; Irwin et al., 2022). As the individual has to maintain wakefulness throughout the day despite the homeostatic sleep pressure caused by the first night of forced awakenings (4 h sleep loss and broken sleep continuity), this maintained wakefulness could represent an additional extended wake period. After the second night of forced awakenings, the net result is accumulation of sleep debt coupled with an episode of extended wakefulness (similar to an acute night of delayed sleep onset), which causes heat and mechanical hypersensitivity. Similarly, platform-over-the-water protocols occur over several days, causing a buildup of sleep debt that increases heat pain hypersensitivity over time. Finally, these dynamic processes could explain how longitudinal protocols where individuals go through stage-specific sleep deprivations followed by total sleep deprivation can lead to complex and sometimes misleading interpretations.
In conclusion, both clinical and preclinical studies confirm a strong effect of sleep disturbances on pain sensitivity in a highly conserved manner. However, different sleep disturbances affect preferentially specific components of the pain response. REMS deprivation is not associated with a strong increase in pain responses, and the major driver for hyperalgesia appears to be the total amount of sleep lost. Further, the dynamics of sleep loss reveal potential mechanistic insights: sleep loss caused by extended wake is strongly associated with heat and mechanical pain hypersensitivity; whereas a similar loss achieved by disrupting sleep continuity causes a loss of diffuse noxious inhibitory controls. Finally, the sleep debt and its deleterious effects on pain sensitivity are cumulative over days, despite a preserved homeostatic sleep rebound, which over time could contribute to the complex pain responses profile observed in chronic sleep disturbances settings.
Part 5: Possible sites for pain modulation by sleep loss
Nociceptive signals can be amplified at many levels along the pain pathways (see Figure 1A). Below we describe where the nociceptive input might be enhanced by acute and chronic sleep loss, and the potential mechanisms.
Nociceptors
Nociceptors can lower their activation threshold, notably when exposed to pro-inflammatory cytokines/chemokines, trophic factors or even foreign bodies (Chiu et al., 2013), a process known as peripheral sensitization. A major source of proinflammatory cytokines are immune cells. Immunity is composed of the innate and the adaptive immune systems and both are heavily regulated by circadian and sleep-wake cycles (Imeri and Opp, 2009; Lange et al., 2010; Besedovsky et al., ; Dimitrov et al., 2015; Irwin and Opp, 2017; Liu et al., 2021) and strongly affected by sleep loss (Bryant et al., ). An acute total sleep loss of 3–4 h is sufficient to alter the innate immune system that consists of monocytes (blood-circulating precursors of macrophages), macrophages, eosinophils, neutrophils, basophils, mast cells, and natural killer cells (NK cells). In particular, the number of circulating neutrophils and monocytes increase after sleep loss in humans (Irwin et al., 2008; Christoffersson et al., 2014; Faraut et al., 2015; Lasselin et al., 2015), rats (Ibarra-Coronado et al., 2015) and mice (Guariniello et al., 2012). In these cells, sleep loss enhances the transcriptional activity of the proinflammatory nuclear factor NFkB, which in turn promotes the production and release of TNFα, IL-1β, IL-6, IL-8, and C-reactive protein (Hu et al., 2003; Haack et al., 2007; Irwin et al., 2008, 2015, 2022; Yehuda et al., 2009; Aho et al., ; Carroll et al., ; Dimitrov et al., 2015). These cytokines can bind to and sensitize nociceptors directly (Brenn et al., ; Binshtok et al., ; Kawasaki et al., 2008; Stemkowski et al., 2015). In addition, IL-1β triggers the induction of cyclooxygenase 2 (COX2) in macrophages (Samad et al., 2001) which leads to the production of the prostaglandin PGE2, a potent sensitizer of nociceptors (Chapman and Dickenson, ; Chen et al., ). PGE2 levels correlate with migraine and headache complaints after sleep deprivation (Haack et al., 2007, 2009). The overall shift into a pro-inflammatory profile while factors that can terminate the immune response (i.e., anti-inflammatory cytokines and chemokines), could extend the duration of inflammation.
T cells and B cells (adaptive immune system) are further classified into helper (Th), regulator (Treg), killer (cytotoxic) and memory T cells, and they produce a highly targeted cellular response that relies on the prior exposure to the foreign bodies. Sleep loss durations lasting from 3 to 21 days affect the adaptive immune system, with an overall downregulation of the “cellular immune response” carried out by Th-1 lymphocytes in favor of Th-2 and Th-17 lymphocytes-mediated responses in humans and rodents (Van Leeuwen et al., 2009; Axelsson et al., ; Nunes et al., 2018). This promotion of Th-2-mediated responses could be further strengthened by PGE2 produced by monocytes/macrophages (Harris et al., 2002). IL-17 directly causes pain (Pinto et al., 2010) by sensitizing nociceptors (Segond von Banchet et al., 2013), while the pro-nociceptive effects of IL-22 are possibly indirectly mediated by neutrophil recruitment (Pinto et al., 2015). IL-22 can also promote the differentiation into Th-2 lymphocyte profile, further amplifying this shift (Lou et al., 2017). Finally, the dysregulation of B cell function after chronic sleep loss impairs the efficiency of immunization (Zielinski and Krueger, 2011; Prather et al., 2012).
Overall, these results indicate that sleep loss initially promotes the proinflammatory component of the innate immune response (monocytes/macrophages, neutrophils) and then a shift toward allergic reactions and autoimmunity at the adaptive immune system level (Th2/Th17). Because these changes are associated with an increase in pronociceptive signaling (IL-6, IL-1β, TNFα) and a reduction of antinociception (IL2), they could contribute to pain hypersensitivity or a delayed recovery after tissue injury. However, administration of the non-specific COX1/2 inhibitor ibuprofen does not reduce acute or chronic sleep loss-induced heat or mechanical evoked pain hypersensitivity (Wodarski et al., 2015; Alexandre et al., ), suggesting a limited role of inflammatory processes in these symptoms. In contrast, spontaneous pain complaints or migraine attacks, whose frequency increases after repeated nights of insufficient sleep (Haack and Mullington, 2005; Haack et al., 2007; Odegard et al., 2011) might be mediated by the sleep loss-induced increase in prostaglandin levels (Haack et al., 2009). Finally, sleep loss-induced increase in IL-6 or TNFα levels might aggravate the defects in emotional status (Hunt et al., 2021), possibly by crossing the blood brain barrier and reaching the mesolimbic system (Hunt et al., 2022) (Figure 7A).
Figure 7
Spinal cord
The spinal cord is a major site for nociceptive signal modulation. Only a small fraction of spinal neurons project to brain structures and they are mostly located in the lamina I and V of the dorsal horns (Todd, 2010). These neurons are under strong modulatory controls, both excitatory and inhibitory that originate both locally (“segmental controls”) and at the supra-spinal level (mostly located within the rostroventral medulla and the pons); (Alexandre et al., ). Changes in the excitatory/inhibitory balance in the dorsal horns of the spinal cord will affect the nociceptive signal sent to the brain. One potent form of spinal plasticity is called central sensitization, which corresponds to a heightened functional state of the spinal nociceptive neurons where their activation threshold is reduced, they produce stronger and longer responses upon activation by noxious stimuli (a symptom referred to as hyperalgesia), and they can be activated by innocuous stimulations (allodynia) (Latremoliere and Woolf, 2009). Sleep loss could enhance spinal excitability by modulating both segmental and supraspinal controls.
Proinflammatory cytokines and PGE2 produced at the periphery after sleep loss can penetrate the spinal cord and promote nociceptive transmission (Baba et al., ; Samad et al., 2001; Latremoliere and Woolf, 2009). In addition, sleep loss increases sensitivity of NMDAR and mGluR in the dorsal horns (Wei et al., 2007, 2010), and this is associated with an increase in mechanical pain in rats. Capsaicin (active ingredient of red-hot chili peppers that activate TRPV1 channels) can be used to trigger central sensitization and measure associated behavioral changes caused by spinal plasticity. Four nights of platform over water paradigm (rats) increased c-fos immunoreactivity in the trigeminal nucleus upon supradural capsaicin infusion, suggesting increased spinal neuronal excitability, or longer time to return to normal sensitivity at the first relay of nociceptive transmission (Kim et al., 2019). After two nights of forced awakenings (humans), women displayed increased windup pain (but not men), while men developed mechanical secondary hyperalgesia (but not women) (Smith et al., 2019). These results indicate a possible spinal amplification of nociceptive signaling with probable sex difference. However, the lack of development of secondary allodynia in sleep-deprived subjects suggests that forced awakenings and moderate sleep loss do not trigger a state of central sensitization (where innocuous stimuli activate spinal nociceptive neurons and cause pain), but rather specifically amplify the nociceptive/pain signal. This amplification could involve a spinal facilitation, suggested by the increase in c-fos spinal staining and windup pain readout (Figure 7B). The increased pain ratings during repeated nociceptive stimulations could also involve supraspinal changes (in brainstem, thalamus, cortex) or an increasing discomfort or anxiety with repeated painful stimulations.
Several lines of evidence suggest sleep loss could also dysregulate descending controls into the spinal cord. Traditional descending inhibitory controls are mostly recruited by the spino-periaqueductal gray (PAG) pathway, which originates from lamina I spinal projection neurons (Gauriau and Bernard, 2002). The PAG is critical for the analgesic effects of morphine (Fields, 2004; Ossipov et al., 2014). Under normal conditions, morphine binds to inhibitory PAG interneurons, which release their brake on glutamatergic PAG neurons that project onto the pain-inhibiting RVM neurons (“OFF-cells”). This disinhibition of RVM “OFF cells” allows the recruitment of inhibitory descending controls. After a single night of sleep deprivation, there is a loss of morphine analgesic efficacity in humans and rodents (Ukponmwan et al., 1984; Nascimento et al., 2007; Steinmiller et al., 2010; Skinner et al., 2011; Alexandre et al., ), which could be due in part to an hyperexcitability of GABAergic PAG interneurons preventing the recruitment of inhibitory descending pathways from the RVM (Tomim et al., 2016).
Administration of amitriptyline, a non-selective 5-HT/NA reuptake inhibitor (which increases levels of these monoamines in the spinal cord), improves heat pain hypersensitivity in rats after sleep loss (but not mechanical pain hypersensitivity), thus supporting the hypothesis of a partial loss of noradrenergic and serotoninergic descending controls (Wei et al., 2008; Wodarski et al., 2015). Amitriptyline has also been shown to be an agonist of Kv7.2/7.3 channels (Punke and Friederich, 2007), and selective activation of these channels phenocopied amitriptyline in sleep-deprived animals (Wodarski et al., 2015), which could suggest Kv7.2/7.3 are involved in sleep loss-induced heat hyperalgesia. However, one caveat is that activation of Kv7.2/7.3 channels causes analgesia in well-rested animals (Teng et al., 2016) and are not restricted to the RVM-spinal projections. Finally, in parallel to this possible loss of inhibitory descending controls, sleep loss increases RVM cholecystokininergic transmission, which promotes pro-nociceptive descending controls (“ON-cells”; Tomim et al., 2016).
Overall, several studies indicate a probable change in spinal-midbrain pathways' excitability after sleep loss. Sleep disturbances do not trigger a frank state of central sensitization, but rather a relative gain in pronociceptive signaling, in part mediated by changes in RVM spinal projections (Figure 7C). Whether this plasticity also involves intrinsic changes within the spinal nociceptive circuits remains unclear.
Brain: Mesolimbic system
While the spino-thalamo-cortical pathway plays a key role for the sensory-discriminative component of pain and the spino-parabrachial pathway generates its emotional (escape and aversive memory) and autonomic (heart rate, pupil dilatation, sweating) components (Gauriau and Bernard, 2002; Tracey et al., 2019; Chiang et al., 2020), several brain areas associated with cognitive and emotional processes can also modulate the final pain response based on its context (e.g., attention to pain, distraction analgesia, pain tolerance, etc.). The mesolimbic system could play a major role in this contextualization of the pain sensation, notably by determining the salience of the stimulus (Knutson et al., 2001; Roitman et al., 2005; Cooper and Knutson, 2008; Al-Hasani et al., ) and by modulating the reward system during and after a pain stimulation (Lammel et al., 2014; Navratilova et al., 2015; Yang et al., 2021). Several lines of evidence have recently pointed to a critical role of the mesolimbic system, notably the nucleus accumbens (NAc) on the proalgesic effects of sleep loss on pain (Finan et al., 2013; Sardi et al., 2018b; Alexandre et al., ). The NAc is subdivided in three functionally distinct areas: the NAc core, the medial part of the NAc shell, and the lateral part of the NAc shell (Lammel et al., 2014), which all likely play a distinct role in the overall pain experience. The NAc core is critical to determine the salience of stimuli (Chen and Bruchas, ), the medial NAc shell is involved in the aversive-encoding prediction of an unpleasant stimulus (including pain) (de Jong et al., 2019); the lateral NAc shell is a key structure for the reward system (Lammel et al., 2014; de Jong et al., 2019). NAc activity is strongly modulated by dopamine released from the ventral tegmental area (VTA) via mostly segregated pathways: the medial VTA projects to the NAc core and the medial NAc shell, while the lateral VTA almost exclusively projects onto the lateral NAc shell (Lammel et al., 2014). A painful stimulation causes an activation of DA neurons located in the most ventral part of the medial VTA (Brischoux et al., ; Lammel et al., 2014; de Jong et al., 2019), presumably reinforcing aversion (de Jong et al., 2019), while it mostly inhibits dopamine release in the lateral NAc shell (de Jong et al., 2019), likely blocking pleasant/reward pathways during ongoing pain. This inhibition of lateral VTA neurons is notably mediated by GABAergic SNR neurons, which are directly contacted by lateral parabrachial nucleus neurons (Yang et al., 2021). At the cessation of the pain stimulation, there is a rebound of dopamine release onto neurons of the lateral NAc shell, a phenomenon known as “pain cessation reward” (Navratilova et al., 2015).
Overall, these studies indicate that the dynamics of dopamine release onto different regions of NAc are extremely important for an adequate pain response. Functional magnetic resonance imaging (fMRI) studies found that sleep loss strongly alters these activation dynamics of NAc upon noxious stimulation (Krause et al., 2019; Seminowicz et al., 2019), notably through a defect in D2R/D3R transmission (Volkow et al., 2008, 2012). In rodents, excitotoxic lesions, local silencing of the NAc (Sardi et al., 2018a,b) or administration of modafinil (Alexandre et al., ), which enhances DAergic tone (Boutrel and Koob, ), normalize pain sensitivity without any analgesic activity on their own. This dysregulation of VTA-NAc function upon painful stimulation after sleep loss could affect how a nociceptive stimulus is evaluated (salience), how pain (or its cessation) is going to be anticipated, or dampen the positive sensation associated with the termination of a painful stimulus. VTA neurons are strongly implicated in sleep-wake behaviors and both DAergic and GABAergic neurons of the VTA are active during wakefulness and quiet during NREMS (Eban-Rothschild et al., 2016). Their sustained activation during extended wake coupled with a limited recovery during shorter sleep opportunity could contribute to the accumulation of sleep loss-induced hyperalgesia. In addition, an increased input from the spinal-parabrachial pathway after sleep loss (originating from lamina I nociceptive neurons) could in turn overactivate SNR GABAergic neurons projecting to the lateral VTA, and thereby contribute to the reduced DAergic transmission onto NAc neurons and disrupt normal activation dynamics of this nucleus upon painful stimulation (Figure 7D).
The majority of NAc neurons expressing D2R express the excitatory adenosine A2A receptors (Valjent et al., 2009) (A2AR). Blockade of A2AR, notably by caffeine, normalizes pain in sleep-deprived animals (Alexandre et al., ; Sardi et al., 2018a) while local administration of A2AR agonists extends sleep loss-induced hyperalgesia in rats (Sardi et al., 2018b). Adenosine accumulates with wakefulness, which would contribute to the overexcitability of NAc neurons during extended wake.
Altogether, these data suggest that sleep loss might lead to a state of hyperexcitability of D2R/A2AR NAc neurons, which would be caused by a combination of reduced function of D2R (internalization, or decoupling of G-protein), but also an accumulation of adenosine during wakefulness activating A2AR (Gq-coupled). Restoring an inhibitory brake on these neurons (by promoting D2R or blocking A2AR) could restore normal pain sensitivity by maintaining the normal excitatory/inhibitory balance required for the different subnuclei of the NAc to function (Figure 7D). Finally, it is worth mentioning that in humans, laser-evoked potential signal was reduced after sleep loss, despite an increase in pain ratings (Tiede et al., 2010; Azevedo et al., ), which would suggest that the nociceptive input might not be increased in higher brain structures, but rather by promoting how the signal is perceived and contextualized—two major features of the mesolimbic system.
Conclusions
Despite significant differences in sleep-wake patterns between humans and rodents and a great heterogeneity in protocols used to disturb sleep, the effects of sleep disturbances on pain sensitivity are remarkably conserved across species. In addition, in all species assessed, females developed more pain hypersensitivity than males, and this might involve distinct neural mechanisms. We propose that the major driver for pain hypersensitivity is the total amount of sleep lost, while REMS loss by itself does not seem to have a direct effect on pain. REMS deprivation however increases the febrile response and might contribute to impaired recovery upon injury (Sutton and Opp, 2014; Wang et al., 2015; Vanini, 2016; Dai et al., 2022). The dynamics of sleep loss might affect different components of the pain response: sleep loss caused by extended wakefulness preferentially increases pain perception, whereas interrupted and limited sleep strongly dysregulates descending controls such as DNIC, especially in women.
Sleep disturbances affect pain pathways at several anatomical levels. Insufficient sleep causes a shift in the immune system toward a proinflammatory profile. While the increase of these proinflammatory factors (notably prostaglandins and cytokines) at the periphery is not sufficient to trigger evoked pain hypersensitivity, these agents might promote migraine as well as the risk of developing abnormal pain after injury (and inflammation). Sleep disturbances might enhance pain transmission at the spinal level, without however causing a state of full central sensitization (i.e., no development of allodynia). This increased spinal excitability has a strong sexual dimorphism, which could be caused by sex-dependent spinal mechanisms or changes from supraspinal structures. For example, sleep disturbances affect DNICs only in women, while men are mostly spared. Sleep loss causes an overexcitability of PAG neurons, which reduces morphine analgesic efficacy and could also alter “traditional” descending controls. Finally, sleep loss caused by an extended wake, similar to that experienced by a large body of the general population, might preferentially affect the mesolimbic system. This system plays a key role in the emotional and cognitive component of the pain response. Sleep loss-induced dysfunctions of the mesolimbic system could increase pain by promoting the attention to pain, amplifying catastrophizing (expectation of when a painful stimulus will stop), and reducing distraction analgesia.
Because the deleterious effects of sleep loss on pain sensitivity are cumulative, they likely contribute to the complex sleep and pain profiles observed in chronic clinical settings. Understanding how specific pain components are dysregulated by different sleep disturbances will help decipher how they interact over time, and the best strategies to promote sleep features that normalize pain sensitivity.
Methodology
We searched for articles studying the effects of sleep disturbances on pain on PubMed and Google Scholar. Key words included “sleep deprivation”; “sleep loss”; “chronic sleep deprivation”; “chronic sleep loss”; “chronic sleep restriction”; “REMS deprivation”; “total sleep deprivation”; “pain”; “nociception” and their combination. For this review, we selected studies that measured evoked pain sensitivity in laboratory settings (no diaries). Only experiments in healthy subjects were used. For animal studies, we only used data from healthy animals (in some cases, non-injured animals that acted as controls to injury models). Determination of pain hypersensitivity (or normal pain sensitivity) was analyzed for all time points reported within the studies. In studies using multiple sleep disruption protocols, we only analyzed the pain results from the first disruption used. If studies not obtained by the PubMed or Google Scholar searches were identified by reading manuscripts, they were added to this study.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.
Author contributions
KK, CA, and AL analyzed the data and wrote the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by NIH grant R01NS112266 (AL) and the Blaustein Pain Research Fund Grants (to AL and CA).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AhoV.OllilaH. M.RantanenV.KronholmE.SurakkaI.Van LeeuwenW. M.et al. (2013). Partial sleep restriction activates immune response-related gene expression pathways: experimental and epidemiological studies in humans. PLoS ONE8, e77184. 10.1371/journal.pone.0077184
2
AlexandreC.LatremoliereA.FerreiraA.MiraccaG.YamamotoM.ScammellT. E.et al. (2017). Decreased alertness due to sleep loss increases pain sensitivity in mice. Nat. Med.23, 768–774. 10.1038/nm.4329
3
AlexandreC.LatremoliereA.FinanP. H. (2020). “Effect of sleep loss on pain,” in The Oxford Handbook of the Neurobiology of Pain (Oxford University Press), 557–608.
4
Al-HasaniR.MccallJ. G.ShinG.GomezA. M.SchmitzG. P.BernardiJ. M.et al. (2015). Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward. Neuron87, 1063–1077. 10.1016/j.neuron.2015.08.019
5
AraujoP.Mazaro-CostaR.TufikS.AndersenM. L. (2011). Impact of sex on hyperalgesia induced by sleep loss. Horm. Behav.59, 174–179. 10.1016/j.yhbeh.2010.11.003
6
ArimaT.SvenssonP.RasmussenC.NielsenK. D.DrewesA. M.Arendt-NielsenL. (2001). The relationship between selective sleep deprivation, nocturnal jaw-muscle activity and pain in healthy men. J. Oral Rehabil.28, 140–148. 10.1046/j.1365-2842.2001.00687.x
7
AserinskyE.KleitmanN. (1953). Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science118, 273–274. 10.1126/science.118.3062.273
8
AxelssonJ.RehmanJ.-U.AkerstedtT.EkmanR.MillerG. E.HöglundC. O.et al. (2013). Effects of sustained sleep restriction on mitogen-stimulated cytokines, chemokines and T helper 1/T helper 2 balance in humans. PLoS ONE8, e82291. 10.1371/journal.pone.0082291
9
AzevedoE.ManzanoG. M.SilvaA.MartinsR.AndersenM. L.TufikS. (2011). The effects of total and REM sleep deprivation on laser-evoked potential threshold and pain perception. Pain152, 2052–2058. 10.1016/j.pain.2011.04.032
10
BabaH.KohnoT.MooreK. A.WoolfC. J. (2001). Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J. Neurosci.21, 1750–1756. 10.1523/JNEUROSCI.21-05-01750.2001
11
BanksS.Van DongenH. P.MaislinG.DingesD. F. (2010). Neurobehavioral dynamics following chronic sleep restriction: dose-response effects of one night for recovery. Sleep33, 1013–1026. 10.1093/sleep/33.8.1013
12
BasbaumA. I.FieldsH. L. (1978). Endogenous pain control mechanisms: review and hypothesis. Ann. Neurol.4, 451–462. 10.1002/ana.410040511
13
BasbaumA. I.FieldsH. L. (1984). Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci.7, 309–338. 10.1146/annurev.ne.07.030184.001521
14
BesedovskyL.LangeT.BornJ. (2012). Sleep and immune function. Pflugers Arch.463, 121–137. 10.1007/s00424-011-1044-0
15
BinshtokA. M.WangH.ZimmermannK.AmayaF.VardehD.ShiL.et al. (2008). Nociceptors are interleukin-1beta sensors. J. Neurosci.28, 14062–14073. 10.1523/JNEUROSCI.3795-08.2008
16
BjurstromM. F.IrwinM. R. (2016). Polysomnographic characteristics in nonmalignant chronic pain populations: A review of controlled studies. Sleep Med. Rev.26, 74–86. 10.1016/j.smrv.2015.03.004
17
BorbelyA. A. (1982). A two process model of sleep regulation. Hum. Neurobiol.1, 195–204.
18
BorbelyA. A.AchermannP. (1999). Sleep homeostasis and models of sleep regulation. J. Biol. Rhythms14, 557–568. 10.1177/074873099129000894
19
BosmaR. L.Ameli MojaradE.LeungL.PukallC.StaudR.StromanP. W. (2015). Neural correlates of temporal summation of second pain in the human brainstem and spinal cord. Hum. Brain Mapp.36, 5038–5050. 10.1002/hbm.22993
20
BouhassiraD.BingZ.Le BarsD. (1992a). Effects of lesions of locus coeruleus/subcoeruleus on diffuse noxious inhibitory controls in the rat. Brain Res.571, 140–144. 10.1016/0006-8993(92)90520-J
21
BouhassiraD.VillanuevaL.BingZ.Le BarsD. (1992b). Involvement of the subnucleus reticularis dorsalis in diffuse noxious inhibitory controls in the rat. Brain Res.595, 353–357. 10.1016/0006-8993(92)91071-L
22
BoutrelB.KoobG. F. (2004). What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep27, 1181–1194. 10.1093/sleep/27.6.1181
23
BrennD.RichterF.SchaibleH. G. (2007). Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum.56, 351–359. 10.1002/art.22282
24
BrischouxF.ChakrabortyS.BrierleyD. I.UnglessM. A. (2009). Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc. Natl. Acad. Sci. U. S. A.106, 4894–4899. 10.1073/pnas.0811507106
25
BryantP. A.TrinderJ.CurtisN. (2004). Sick and tired: does sleep have a vital role in the immune system?Nat. Rev. Immunol.4, 457–467. 10.1038/nri1369
26
BuschV.HaasJ.CronleinT.PiehC.GeislerP.HajakG.et al. (2012). Sleep deprivation in chronic somatoform pain-effects on mood and pain regulation. Psychiatry Res.195, 134–143. 10.1016/j.psychres.2011.07.021
27
CarrollJ. E.CarrilloC.OlmsteadR.WitaramaT.BreenE. C.YokomizoM.et al. (2015). Sleep deprivation and divergent toll-like receptor-4 activation of cellular inflammation in aging. Sleep38, 205–211. 10.5665/sleep.4398
28
ChapmanV.DickensonA. H. (1992). The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur. J. Pharmacol.219, 427–433. 10.1016/0014-2999(92)90484-L
29
ChenJ.BruchasM. (2021). Neuromodulation: a model for dopamine in salience encoding. Curr. Biol.31, R1426–R1429. 10.1016/j.cub.2021.09.038
30
ChenX.TannerK.LevineJ. D. (1999). Mechanical sensitization of cutaneous C-fiber nociceptors by prostaglandin E2 in the rat. Neurosci. Lett.267, 105–108. 10.1016/S0304-3940(99)00345-6
31
ChiangM. C.NguyenE. K.Canto-BustosM.PapaleA. E.OswaldA. M.RossS. E. (2020). Divergent neural pathways emanating from the lateral parabrachial nucleus mediate distinct components of the pain response. Neuron106, 927–939.e5. 10.1016/j.neuron.2020.03.014
32
ChiuI. M.HeestersB. A.GhasemlouN.Von HehnC. A.ZhaoF.TranJ.et al. (2013). Bacteria activate sensory neurons that modulate pain and inflammation. Nature501, 52–57. 10.1038/nature12479
33
ChouchouF.ChaunyJ. M.RainvilleP.LavigneG. J. (2015). Selective REM sleep deprivation improves expectation-related placebo analgesia. PLoS ONE10, e0144992. 10.1371/journal.pone.0144992
34
ChristofferssonG.VagesjoE.PetterssonU. S.MassenaS.NilssonE. K.BromanJ. E.et al. (2014). Acute sleep deprivation in healthy young men: impact on population diversity and function of circulating neutrophils. Brain Behav. Immun.41, 162–172. 10.1016/j.bbi.2014.05.010
35
CoenenA.Van LuijtelaarE. (1985). Stress induced by three procedures of deprivation of paradoxical sleep. Physiol. Behav.35, 501–504. 10.1016/0031-9384(85)90130-1
36
CooperJ. C.KnutsonB. (2008). Valence and salience contribute to nucleus accumbens activation. Neuroimage39, 538–547. 10.1016/j.neuroimage.2007.08.009
37
DaiY.LiuS.ChenJ.LiuL.ZhouC.ZuoY. (2022). Microglial responses and pain behaviors are exacerbated by chronic sleep deprivation in rats with chronic pain via neuroinflammatory pathways. Neuroscience503, 83–94. 10.1016/j.neuroscience.2022.09.004
38
DamascenoF.SkinnerG. O.GomesA.AraujoP. C.De AlmeidaO. M. (2009). Systemic amitriptyline administration does not prevent the increased thermal response induced by paradoxical sleep deprivation. Pharmacol. Biochem. Behav.94, 51–55. 10.1016/j.pbb.2009.07.005
39
de JongJ. W.AfjeiS. A.Pollak DorocicI.PeckJ. R.LiuC.KimC. K.et al. (2019). A neural circuit mechanism for encoding aversive stimuli in the mesolimbic dopamine system. Neuron101, 133–151.e7. 10.1016/j.neuron.2018.11.005
40
Diaz-PiedraC.CatenaA.SanchezA. I.MiroE.MartinezM. P.Buela-CasalG. (2015). Sleep disturbances in fibromyalgia syndrome: the role of clinical and polysomnographic variables explaining poor sleep quality in patients. Sleep Med.16, 917–925. 10.1016/j.sleep.2015.03.011
41
DimitrovS.BesedovskyL.BornJ.LangeT. (2015). Differential acute effects of sleep on spontaneous and stimulated production of tumor necrosis factor in men. Brain Behav. Immun.47, 201–210. 10.1016/j.bbi.2014.11.017
42
DrewesA. M.RosselP.Arendt-NielsenL.NielsenK. D.HansenL. M.Birket-SmithL.et al. (1997). Sleepiness does not modulate experimental joint pain in healthy volunteers. Scand. J. Rheumatol.26, 399–400. 10.3109/03009749709065709
43
Eban-RothschildA.RothschildG.GiardinoW. J.JonesJ. R.De LeceaL. (2016). VTA dopaminergic neurons regulate ethologically relevant sleep-wake behaviors. Nat. Neurosci.19, 1356–1366. 10.1038/nn.4377
44
EdwardsR. R.GraceE.PetersonS.KlickB.HaythornthwaiteJ. A.SmithM. T. (2009). Sleep continuity and architecture: associations with pain-inhibitory processes in patients with temporomandibular joint disorder. Eur. J. Pain13, 1043–1047. 10.1016/j.ejpain.2008.12.007
45
EichhornN.TreedeR. D.Schuh-HoferS. (2018). The role of sex in sleep deprivation related changes of nociception and conditioned pain modulation. Neuroscience387, 191–200. 10.1016/j.neuroscience.2017.09.044
46
EversonC. A.SzaboA. (2011). Repeated exposure to severely limited sleep results in distinctive and persistent physiological imbalances in rats. PLoS ONE6, e22987. 10.1371/journal.pone.0022987
47
FarautB.BoudjeltiaK. Z.VanhammeL.KerkhofsM. (2012). Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med. Rev.16, 137–149. 10.1016/j.smrv.2011.05.001
48
FarautB.LegerD.MedkourT.DuboisA.BayonV.ChennaouiM.et al. (2015). Napping reverses increased pain sensitivity due to sleep restriction. PLoS ONE10, e0117425. 10.1371/journal.pone.0117425
49
FieldsH. (2004). State-dependent opioid control of pain. Nat. Rev. Neurosci.5, 565. 10.1038/nrn1431
50
FinanP. H.GoodinB. R.SmithM. T. (2013). The association of sleep and pain: an update and a path forward. J. Pain14, 1539–1552. 10.1016/j.jpain.2013.08.007
51
FinanP. H.QuartanaP. J.RemeniukB.GarlandE. L.RhudyJ. L.HandM.et al. (2017). Partial sleep deprivation attenuates the positive affective system: effects across multiple measurement modalities. Sleep 40, zsw017. 10.1093/sleep/zsw017
52
FranzenP. L.BuysseD. J.DahlR. E.ThompsonW.SiegleG. J. (2009). Sleep deprivation alters pupillary reactivity to emotional stimuli in healthy young adults. Biol. Psychol.80, 300–305. 10.1016/j.biopsycho.2008.10.010
53
FreireC.SennesL. U.PolotskyV. Y. (2022). Opioids and obstructive sleep apnea. J. Clin. Sleep Med.18, 647–652. 10.5664/jcsm.9730
54
GauriauC.BernardJ. F. (2002). Pain pathways and parabrachial circuits in the rat. Exp. Physiol.87, 251–258. 10.1113/eph8702357
55
GoelN.RaoH.DurmerJ. S.DingesD. F. (2009). Neurocognitive consequences of sleep deprivation. Semin. Neurol.29, 320–339. 10.1055/s-0029-1237117
56
GrahnstedtS.UrsinR. (1985). Platform sleep deprivation affects deep slow wave sleep in addition to REM sleep. Behav. Brain Res.18, 233–239. 10.1016/0166-4328(85)90031-2
57
GuarinielloL. D.VicariP.LeeK. S.De OliveiraA. C.TufikS. (2012). Bone marrow and peripheral white blood cells number is affected by sleep deprivation in a murine experimental model. J. Cell. Physiol.227, 361–366. 10.1002/jcp.22743
58
GurelE. E.UralK.OzturkG.OzturkL. (2014). Flurbiprofen in rapid eye movement sleep deprivation induced hyperalgesia. Physiol. Behav.128, 155–158. 10.1016/j.physbeh.2014.02.003
59
HaackM.LeeE.CohenD. A.MullingtonJ. M. (2009). Activation of the prostaglandin system in response to sleep loss in healthy humans: potential mediator of increased spontaneous pain. Pain145, 136–141. 10.1016/j.pain.2009.05.029
60
HaackM.MullingtonJ. M. (2005). Sustained sleep restriction reduces emotional and physical well-being. Pain119, 56–64. 10.1016/j.pain.2005.09.011
61
HaackM.SanchezE.MullingtonJ. M. (2007). Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep30, 1145–1152. 10.1093/sleep/30.9.1145
62
Hambrecht-WiedbuschV. S.GabelM.LiuL. J.ImperialJ. P.ColmeneroA. V.VaniniG. (2017). Preemptive caffeine administration blocks the increase in postoperative pain caused by previous sleep loss in the rat: a potential role for preoptic adenosine A2A receptors in sleep-pain interactions. Sleep 40. 10.1093/sleep/zsx116
63
HarrisS. G.PadillaJ.KoumasL.RayD.PhippsR. P. (2002). Prostaglandins as modulators of immunity. Trends Immunol.23, 144–150. 10.1016/S1471-4906(01)02154-8
64
HarveyM. T.KlineR. H. T.MayM. E.RobertsA. C.ValdovinosM. G.WileyR. G.et al. (2010). Parametric analysis of thermal preference following sleep deprivation in the rat. Neurosci. Lett.485, 98–101. 10.1016/j.neulet.2010.08.070
65
HicksR. A.ColemanD. D.FerranteF.SahatjianM.HawkinsJ. (1979). Pain thresholds in rats during recovery from REM sleep deprivation. Percept. Mot. Skills48, 687–690. 10.2466/pms.1979.48.3.687
66
HolingueC.WennbergA.BergerS.PolotskyV. Y.SpiraA. P. (2018). Disturbed sleep and diabetes: A potential nexus of dementia risk. Metab. Clin. Exp.84, 85–93. 10.1016/j.metabol.2018.01.021
67
HouleT. T.ButschekR. A.TurnerD. P.SmithermanT. A.RainsJ. C.PenzienD. B. (2012). Stress and sleep duration predict headache severity in chronic headache sufferers. Pain153, 2432–2440. 10.1016/j.pain.2012.08.014
68
HuJ.ChenZ.GorczynskiC.GorczynskiL.KaiY.LeeL.et al. (2003). Sleep-deprived mice show altered cytokine production manifest by perturbations in serum IL-1ra, TNFa, and IL-6 levels. Brain Behav. Immun.17, 498–504. 10.1016/j.bbi.2003.03.001
69
HuntC. A.MunC. J.OwensM. A.LermanS. F.KunatharajuS.TennenH. A.et al. (2022). Sleep, positive affect, and circulating interleukin-6 in women with temporomandibular joint disorder. Psychosom. Med.84, 383–392. 10.1097/PSY.0000000000001047
70
HuntC. A.SmithM. T.MunC. J.IrwinM. R.FinanP. H. (2021). Trait positive affect buffers the association between experimental sleep disruption and inflammation. Psychoneuroendocrinology129, 105240. 10.1016/j.psyneuen.2021.105240
71
IacovidesS.GeorgeK.KamermanP.BakerF. C. (2017). Sleep fragmentation hypersensitizes healthy young women to deep and superficial experimental pain. J Pain18, 844–854. 10.1016/j.jpain.2017.02.436
72
Ibarra-CoronadoE. G.Velazquéz-MoctezumaJ.DiazD.Becerril-VillanuevaL. E.PavónL.Morales-MontorJ. (2015). Sleep deprivation induces changes in immunity in Trichinella spiralis-infected rats. Int. J. Biol. Sci.11, 901. 10.7150/ijbs.11907
73
ImeriL.OppM. R. (2009). How (and why) the immune system makes us sleep. Nat. Rev. Neurosci.10, 199–210. 10.1038/nrn2576
74
IrwinM. R.OlmsteadR.BjurstromM. F.FinanP. H.SmithM. T. (2022). Sleep disruption and activation of cellular inflammation mediate heightened pain sensitivity: a randomized clinical trial. Pain. 10.1097/j.pain.0000000000002811
75
IrwinM. R.OlmsteadR.CarrollJ. E. (2016). Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol. Psychiatry80, 40–52. 10.1016/j.biopsych.2015.05.014
76
IrwinM. R.OppM. R. (2017). Sleep health: reciprocal regulation of sleep and innate immunity. Neuropsychopharmacology42, 129–155. 10.1038/npp.2016.148
77
IrwinM. R.WangM.RibeiroD.ChoH. J.OlmsteadR.BreenE. C.et al. (2008). Sleep loss activates cellular inflammatory signaling. Biol. Psychiatry64, 538–540. 10.1016/j.biopsych.2008.05.004
78
IrwinM. R.WitaramaT.CaudillM.OlmsteadR.BreenE. C. (2015). Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain Behav. Immun.47, 86–92. 10.1016/j.bbi.2014.09.017
79
JouvetD.VimontP.DelormeF. (1964). Étude de la privation sélective de la phase paradoxale du sommeil chez le chat.J. Physiol.
80
JungC. M.RondaJ. M.CzeislerC. A.WrightK. P.Jr. (2011). Comparison of sustained attention assessed by auditory and visual psychomotor vigilance tasks prior to and during sleep deprivation. J. Sleep Res.20, 348–355. 10.1111/j.1365-2869.2010.00877.x
81
KawasakiY.ZhangL.ChengJ. K.JiR. R. (2008). Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci.28, 5189–5194. 10.1523/JNEUROSCI.3338-07.2008
82
KimS. H.ParkJ. Y.ShinH. E.LeeS. B.RyuD. W.KimT. W.et al. (2019). The influence of rapid eye movement sleep deprivation on nociceptive transmission and the duration of facial allodynia in rats: a behavioral and Fos immunohistochemical study. J. Headache Pain20, 21. 10.1186/s10194-019-0977-0
83
KnutsonB.AdamsC. M.FongG. W.HommerD. (2001). Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 21, RC159. 10.1523/JNEUROSCI.21-16-j0002.2001
84
KohansiehM.MakaryusA. N. (2015). Sleep deficiency and deprivation leading to cardiovascular disease. Int. J. Hypertens.2015, 5. 10.1155/2015/615681
85
KrauseA. J.PratherA. A.WagerT. D.LindquistM. A.WalkerM. P. (2019). The pain of sleep loss: a brain characterization in humans. J. Neurosci.39, 2291–2300. 10.1523/JNEUROSCI.2408-18.2018
86
KucharczykM. W.Di DomenicoF.BannisterK. (2022). Distinct brainstem to spinal cord noradrenergic pathways inversely regulate spinal neuronal activity. Brain. 145:2293–2300. 10.1093/brain/awac085
87
KundermannB.Hemmeter-SpernalJ.HuberM. T.KriegJ. C.LautenbacherS. (2008). Effects of total sleep deprivation in major depression: overnight improvement of mood is accompanied by increased pain sensitivity and augmented pain complaints. Psychosom. Med.70, 92–101. 10.1097/PSY.0b013e31815c1b5d
88
KundermannB.SpernalJ.HuberM. T.KriegJ. C.LautenbacherS. (2004). Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom. Med.66, 932–937. 10.1097/01.psy.0000145912.24553.c0
89
LammelS.LimB. K.MalenkaR. C. (2014). Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology76, 351–359. 10.1016/j.neuropharm.2013.03.019
90
LangeT.DimitrovS.BornJ. (2010). Effects of sleep and circadian rhythm on the human immune system. Ann. N. Y. Acad. Sci.1193, 48–59. 10.1111/j.1749-6632.2009.05300.x
91
LarsonR. A.CarterJ. R. (2016). Total sleep deprivation and pain perception during cold noxious stimuli in humans. Scand. J. Pain13, 12–16. 10.1016/j.sjpain.2016.05.037
92
LasselinJ.RehmanJ. U.AkerstedtT.LekanderM.AxelssonJ. (2015). Effect of long-term sleep restriction and subsequent recovery sleep on the diurnal rhythms of white blood cell subpopulations. Brain Behav. Immun.47, 93–99. 10.1016/j.bbi.2014.10.004
93
LatremoliereA.WoolfC. J. (2009). Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain10, 895–926. 10.1016/j.jpain.2009.06.012
94
LautenbacherS.KundermannB.KriegJ. C. (2006). Sleep deprivation and pain perception. Sleep Med. Rev.10, 357–369. 10.1016/j.smrv.2005.08.001
95
LautenbacherS.RollmanG. B. (1997). Possible deficiencies of pain modulation in fibromyalgia. Clin. J. Pain13, 189–196. 10.1097/00002508-199709000-00003
96
Le BarsD. (2002). The whole body receptive field of dorsal horn multireceptive neurones. Brain Res. Rev.40, 29–44. 10.1016/S0165-0173(02)00186-8
97
Le BarsD.VillanuevaL.BouhassiraD.WillerJ. C. (1992). Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol. Fiziol. Eksp. Ter.55–65.
98
Leite-AlmeidaH.Valle-FernandesA.AlmeidaA. (2006). Brain projections from the medullary dorsal reticular nucleus: an anterograde and retrograde tracing study in the rat. Neuroscience140, 577–595. 10.1016/j.neuroscience.2006.02.022
99
LentzM. J.LandisC. A.RothermelJ.ShaverJ. L. (1999). Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J. Rheumatol.26, 1586–1592.
100
LetzenJ. E.RemeniukB.SmithM. T.IrwinM. R.FinanP. H.SeminowiczD. A. (2020). Individual differences in pain sensitivity are associated with cognitive network functional connectivity following one night of experimental sleep disruption. Hum. Brain Mapp.41, 581–593. 10.1002/hbm.24824
101
LiY. D.GeJ.LuoY. J.XuW.WangJ.LazarusM.et al. (2020). High cortical delta power correlates with aggravated allodynia by activating anterior cingulate cortex GABAergic neurons in neuropathic pain mice. Pain161, 288–299. 10.1097/j.pain.0000000000001725
102
LiberalessoP. B.D'andreaK. F.CordeiroM. L.ZeigelboimB. S.MarquesJ. M.JurkiewiczA. L. (2012). Effects of sleep deprivation on central auditory processing. BMC Neurosci.13, 83. 10.1186/1471-2202-13-83
103
LiuP. Y.IrwinM. R.KruegerJ. M.GaddameedhiS.Van DongenH. P. A. (2021). Night shift schedule alters endogenous regulation of circulating cytokines. Neurobiol. Sleep Circadian Rhythms10, 100063. 10.1016/j.nbscr.2021.100063
104
LouH.LuJ.ChoiE. B.OhM. H.JeongM.BarmettlerS.et al. (2017). Expression of IL-22 in the skin causes Th2-biased immunity, epidermal barrier dysfunction, and pruritus via stimulating epithelial Th2 cytokines and the GRP pathway. J. Immunol.198, 2543–2555. 10.4049/jimmunol.1600126
105
MachadoR. B.HipolideD. C.Benedito-SilvaA. A.TufikS. (2004). Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery. Brain Res.1004, 45–51. 10.1016/j.brainres.2004.01.019
106
MatreD.AndersenM. R.KnardahlS.NilsenK. B. (2016). Conditioned pain modulation is not decreased after partial sleep restriction. Eur. J. Pain20, 408–416. 10.1002/ejp.741
107
MatreD.HuL.VikenL. A.HjelleI. B.WigemyrM.KnardahlS.et al. (2015). Experimental sleep restriction facilitates pain and electrically induced cortical responses. Sleep38, 1607–1617. 10.5665/sleep.5058
108
MatreD.KnardahlS.NilsenK. B. (2017). Night-shift work is associated with increased pain perception. Scand. J. Work Environ. Health43, 260–268. 10.5271/sjweh.3627
109
MayM. E.HarveyM. T.ValdovinosM. G.KlineR. H. T.WileyR. G.KennedyC. H. (2005). Nociceptor and age specific effects of REM sleep deprivation induced hyperalgesia. Behav. Brain Res.159, 89–94. 10.1016/j.bbr.2004.10.005
110
McHillA. W.HullJ. T.WangW.CzeislerC. A.KlermanE. B. (2018). Chronic sleep curtailment, even without extended (>16-h) wakefulness, degrades human vigilance performance. Proc. Nat. Acad. Sci.115, 6070–6075. 10.1073/pnas.1706694115
111
MendelsonW. B.GuthrieR. D.FrederickG.WyattR. J. (1974). The flower pot technique of rapid eye movement (REM) sleep deprivation. Pharmacol. Biochem. Behav.2, 553–556. 10.1016/0091-3057(74)90018-5
112
MoldofskyH.ScarisbrickP. (1976). Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom. Med. 38:35–44. 10.1097/00006842-197601000-00006
113
MoldofskyH.ScarisbrickP.EnglandR.SmytheH. (1975). Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom. Med.37, 341–351. 10.1097/00006842-197507000-00008
114
NascimentoD. C.AndersenM. L.HipolideD. C.NobregaJ. N.TufikS. (2007). Pain hypersensitivity induced by paradoxical sleep deprivation is not due to altered binding to brain mu-opioid receptors. Behav. Brain Res.178, 216–220. 10.1016/j.bbr.2006.12.016
115
NasehiM.Mosavi-NezhadS. M.KhakpaiF.ZarrindastM. R. (2018). The role of omega-3 on modulation of cognitive deficiency induced by REM sleep deprivation in rats. Behav. Brain Res.351, 152–160. 10.1016/j.bbr.2018.06.002
116
National Sleep Foundation (2015). 2015 sleep in America poll -pain and sleep. Sleep Health1, e14–e375. 10.1016/j.sleh.2015.02.005
117
NavratilovaE.AtcherleyC. W.PorrecaF. (2015). Brain circuits encoding reward from pain relief. Trends Neurosci.38, 741–750. 10.1016/j.tins.2015.09.003
118
NunesJ. O.De Souza ApostolicoJ.AndradeD. A.RuizF. S.FernandesE. R.AndersenM. L.et al. (2018). Sleep deprivation predisposes allergic mice to neutrophilic lung inflammation. J. Allergy Clin. Immunol.141, 1018–1027.e4. 10.1016/j.jaci.2017.06.025
119
OdegardS. S.OmlandP. M.NilsenK. B.StjernM.GravdahlG. B.SandT. (2015). The effect of sleep restriction on laser evoked potentials, thermal sensory and pain thresholds and suprathreshold pain in healthy subjects. Clin. Neurophysiol.126, 1979–1987. 10.1016/j.clinph.2014.12.011
120
OdegardS. S.SandT.EngstromM.StovnerL. J.ZwartJ. A.HagenK. (2011). The long-term effect of insomnia on primary headaches: a prospective population-based cohort study (HUNT-2 and HUNT-3). Headache51, 570–580. 10.1111/j.1526-4610.2011.01859.x
121
OlderS. A.BattafaranoD. F.DanningC. L.WardJ. A.GradyE. P.DermanS.et al. (1998). The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects; correlations with insulin-like growth factor I. J. Rheumatol.25, 1180–1186.
122
OnenS. H.AllouiA.EschalierA.DubrayC. (2000). Vocalization thresholds related to noxious paw pressure are decreased by paradoxical sleep deprivation and increased after sleep recovery in rat. Neurosci. Lett.291, 25–28. 10.1016/S0304-3940(00)01383-5
123
OnenS. H.AllouiA.GrossA.EschallierA.DubrayC. (2001). The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J. Sleep Res.10, 35–42. 10.1046/j.1365-2869.2001.00240.x
124
OssipovM. H.MorimuraK.PorrecaF. (2014). Descending pain modulation and chronification of pain. Curr. Opin. Support. Palliat. Care8, 143. 10.1097/SPC.0000000000000055
125
PageG. G.OppM. R.KozachikS. L. (2014). Reduced sleep, stress responsivity, and female sex contribute to persistent inflammation-induced mechanical hypersensitivity in rats. Brain Behav. Immun.40, 244–251. 10.1016/j.bbi.2014.02.013
126
PalmaJ.-A.UrrestarazuE.IriarteJ. (2013). Sleep loss as risk factor for neurologic disorders: a review. Sleep Med.14, 229–236. 10.1016/j.sleep.2012.11.019
127
PintoL. G.CunhaT. M.VieiraS. M.LemosH. P.VerriW. A.Jr.CunhaF. Q.et al. (2010). IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain148, 247–256. 10.1016/j.pain.2009.11.006
128
PintoL. G.TalbotJ.PeresR. S.FrancaR. F.FerreiraS. H.RyffelB.et al. (2015). Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1beta production. Arthritis Res. Ther.17, 235. 10.1186/s13075-015-0759-2
129
PratherA. A.HallM.FuryJ. M.RossD. C.MuldoonM. F.CohenS.et al. (2012). Sleep and antibody response to hepatitis B vaccination. Sleep35, 1063–1069. 10.5665/sleep.1990
130
PunkeM. A.FriederichP. (2007). Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels. Anesth. Analg.104, 1256–1264. 10.1213/01.ane.0000260310.63117.a2
131
RinggoldK. M.BarfR. P.GeorgeA.SuttonB. C.OppM. R. (2013). Prolonged sleep fragmentation of mice exacerbates febrile responses to lipopolysaccharide. J. Neurosci. Methods219, 104–112. 10.1016/j.jneumeth.2013.07.008
132
RoehrsT.HydeM.BlaisdellB.GreenwaldM.RothT. (2006). Sleep loss and REM sleep loss are hyperalgesic. Sleep29, 145–151. 10.1093/sleep/29.2.145
133
RoitmanM. F.WheelerR. A.CarelliR. M. (2005). Nucleus accumbens neurons are innately tuned for rewarding and aversive taste stimuli, encode their predictors, and are linked to motor output. Neuron45, 587–597. 10.1016/j.neuron.2004.12.055
134
RosselandR.PallesenS.NordhusI. H.MatreD.BlagestadT. (2018). Effects of sleep fragmentation and induced mood on pain tolerance and pain sensitivity in young healthy adults. Front. Psychol.9, 2089. 10.3389/fpsyg.2018.02089
135
SamadT. A.MooreK. A.SapirsteinA.BilletS.AllchorneA.PooleS.et al. (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature410, 471–475. 10.1038/35068566
136
SardiN. F.LazzarimM. K.GuilhenV. A.MarcilioR. S.NatumeP. S.WatanabeT. C.et al. (2018a). Chronic sleep restriction increases pain sensitivity over time in a periaqueductal gray and nucleus accumbens dependent manner. Neuropharmacology139, 52–60. 10.1016/j.neuropharm.2018.06.022
137
SardiN. F.TobaldiniG.MoraisR. N.FischerL. (2018b). Nucleus accumbens mediates the pronociceptive effect of sleep deprivation: the role of adenosine A2A and dopamine D2 receptors. Pain159, 75–84. 10.1097/j.pain.0000000000001066
138
SchererM. R.ClaroP. J.HeatonK. J. (2013). Sleep deprivation has no effect on dynamic visual acuity in military service members who are healthy. Phys. Ther.93, 1185–1196. 10.2522/ptj.20120144
139
SchrimpfM.LieglG.BoeckleM.LeitnerA.GeislerP.PiehC. (2015). The effect of sleep deprivation on pain perception in healthy subjects: a meta-analysis. Sleep Med.16, 1313–1320. 10.1016/j.sleep.2015.07.022
140
Schuh-HoferS.WodarskiR.PfauD. B.CaspaniO.MagerlW.KennedyJ. D.et al. (2013). One night of total sleep deprivation promotes a state of generalized hyperalgesia: a surrogate pain model to study the relationship of insomnia and pain. Pain154, 1613–1621. 10.1016/j.pain.2013.04.046
141
Segond von BanchetG.BoettgerM. K.KonigC.IwakuraY.BrauerR.SchaibleH. G. (2013). Neuronal IL-17 receptor upregulates TRPV4 but not TRPV1 receptors in DRG neurons and mediates mechanical but not thermal hyperalgesia. Mol. Cell. Neurosci.52, 152–160. 10.1016/j.mcn.2012.11.006
142
SeminowiczD. A.RemeniukB.KrimmelS. R.SmithM. T.BarrettF. S.WulffA. B.et al. (2019). Pain-related nucleus accumbens function: modulation by reward and sleep disruption. Pain160, 1196–1207. 10.1097/j.pain.0000000000001498
143
SimonE. B.OrenN.SharonH.KirschnerA.GoldwayN.Okon-SingerH.et al. (2015). Losing neutrality: the neural basis of impaired emotional control without sleep. J. Neurosci.35, 13194–13205. 10.1523/JNEUROSCI.1314-15.2015
144
SkinnerG. O.DamascenoF.GomesA.De AlmeidaO. M. (2011). Increased pain perception and attenuated opioid antinociception in paradoxical sleep-deprived rats are associated with reduced tyrosine hydroxylase staining in the periaqueductal gray matter and are reversed by L-dopa. Pharmacol. Biochem. Behav.99, 94–99. 10.1016/j.pbb.2011.04.009
145
SmithM.RemeniukB.FinanP.SpeedT.TompkinsD.RobinsonM.et al. (2019). Sex differences in measures of central sensitization and pain sensitivity to experimental sleep disruption: implications for sex differences in chronic pain. Sleep 42, zsy209. 10.1093/sleep/zsy209
146
SmithM. T.EdwardsR. R.MccannU. D.HaythornthwaiteJ. A. (2007). The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep30, 494–505. 10.1093/sleep/30.4.494
147
SmithM. T.HaythornthwaiteJ. A. (2004). How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med. Rev.8, 119–132. 10.1016/S1087-0792(03)00044-3
148
SpiegelK.LeproultR.Van CauterE. (1999). Impact of sleep debt on metabolic and endocrine function. Lancet354, 1435–1439. 10.1016/S0140-6736(99)01376-8
149
StaffeA. T.BechM. W.ClemmensenS. L. K.NielsenH. T.LarsenD. B.PetersenK. K. (2019). Total sleep deprivation increases pain sensitivity, impairs conditioned pain modulation and facilitates temporal summation of pain in healthy participants. PLoS ONE14, e0225849. 10.1371/journal.pone.0225849
150
SteinmillerC. L.RoehrsT. A.HarrisE.HydeM.GreenwaldM. K.RothT. (2010). Differential effect of codeine on thermal nociceptive sensitivity in sleepy versus nonsleepy healthy subjects. Exp. Clin. Psychopharmacol.18, 277. 10.1037/a0018899
151
StemkowskiP. L.NohM. C.ChenY.SmithP. A. (2015). Increased excitability of medium-sized dorsal root ganglion neurons by prolonged interleukin-1beta exposure is K(+) channel dependent and reversible. J. Physiol.593, 3739–3755. 10.1113/JP270905
152
SuttonB. C.OppM. R. (2014). Sleep fragmentation exacerbates mechanical hypersensitivity and alters subsequent sleep-wake behavior in a mouse model of musculoskeletal sensitization. Sleep37, 515–524. 10.5665/sleep.3488
153
TasaliE.LeproultR.EhrmannD. A.Van CauterE. (2008). Slow-wave sleep and the risk of type 2 diabetes in humans. Proc. Nat. Acad. Sci.105, 1044–1049. 10.1073/pnas.0706446105
154
TengB. C.SongY.ZhangF.MaT. Y.QiJ. L.ZhangH. L.et al. (2016). Activation of neuronal Kv7/KCNQ/M-channels by the opener QO58-lysine and its anti-nociceptive effects on inflammatory pain in rodents. Acta Pharmacol. Sin.37, 1054–1062. 10.1038/aps.2016.33
155
TiedeW.MagerlW.BaumgartnerU.DurrerB.EhlertU.TreedeR. D. (2010). Sleep restriction attenuates amplitudes and attentional modulation of pain-related evoked potentials, but augments pain ratings in healthy volunteers. Pain148, 36–42. 10.1016/j.pain.2009.08.029
156
TobaldiniE.PecisM.MontanoN. (2014). Effects of acute and chronic sleep deprivation on cardiovascular regulation. Arch. Ital. Biol.152, 103–110.
157
ToblerI.DeboerT.FischerM. (1997). Sleep and sleep regulation in normal and prion protein-deficient mice. J. Neurosci.17, 1869–1879. 10.1523/JNEUROSCI.17-05-01869.1997
158
ToddA. J. (2010). Neuronal circuitry for pain processing in the dorsal horn. Nat. Rev. Neurosci.11, 823–836. 10.1038/nrn2947
159
TomimD. H.PontarollaF. M.BertoliniJ. F.AraseM.TobaldiniG.LimaM. M. S.et al. (2016). The pronociceptive effect of paradoxical sleep deprivation in rats: evidence for a role of descending pain modulation mechanisms. Mol. Neurobiol.53, 1706–1717. 10.1007/s12035-014-9059-0
160
TraceyI.WoolfC. J.AndrewsN. A. (2019). Composite pain biomarker signatures for objective assessment and effective treatment. Neuron101, 783–800. 10.1016/j.neuron.2019.02.019
161
UkponmwanO. E.RuprehtJ.DzoljicM. R. (1984). REM sleep deprivation decreases the antinociceptive property of enkephalinase-inhibition, morphine and cold-water-swim. Gen. Pharmacol.15, 255–258. 10.1016/0306-3623(84)90170-8
162
ValjentE.Bertran-GonzalezJ.HerveD.FisoneG.GiraultJ. A. (2009). Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. Trends Neurosci.32, 538–547. 10.1016/j.tins.2009.06.005
163
Van CauterE.SpiegelK.TasaliE.LeproultR. (2008). Metabolic consequences of sleep and sleep loss. Sleep Med.9, S23–S28. 10.1016/S1389-9457(08)70013-3
164
Van DongenH. P.MaislinG.MullingtonJ. M.DingesD. F. (2003). The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep26, 117–126. 10.1093/sleep/26.2.117
165
Van LeeuwenW. M.LehtoM.KarisolaP.LindholmH.LuukkonenR.SallinenM.et al. (2009). Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS ONE4, e4589. 10.1371/journal.pone.0004589
166
VaniniG. (2016). Sleep deprivation and recovery sleep prior to a noxious inflammatory insult influence characteristics and duration of pain. Sleep39, 133–142. 10.5665/sleep.5334
167
VaniniG.NemanisK.BaghdoyanH. A.LydicR. (2014). GABAergic transmission in rat pontine reticular formation regulates the induction phase of anesthesia and modulates hyperalgesia caused by sleep deprivation. Eur. J. Neurosci.40, 2264–2273. 10.1111/ejn.12571
168
VillanuevaL.BernardJ. F.Le BarsD. (1995). Distribution of spinal cord projections from the medullary subnucleus reticularis dorsalis and the adjacent cuneate nucleus: a Phaseolus vulgaris-leucoagglutinin study in the rat. J. Comp. Neurol.352, 11–32. 10.1002/cne.903520103
169
VillanuevaL.Le BarsD. (1995). The activation of bulbo-spinal controls by peripheral nociceptive inputs: diffuse noxious inhibitory controls. Biol. Res.28, 113–125.
170
VolkowN. D.TomasiD.WangG. J.TelangF.FowlerJ. S.LoganJ.et al. (2012). Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain. J. Neurosci.32, 6711–6717. 10.1523/JNEUROSCI.0045-12.2012
171
VolkowN. D.WangG. J.TelangF.FowlerJ. S.LoganJ.WongC.et al. (2008). Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. J. Neurosci.28, 8454–8461. 10.1523/JNEUROSCI.1443-08.2008
172
WalkerM. P. (2009). The role of sleep in cognition and emotion. Ann. N. Y. Acad. Sci.1156, 168–197. 10.1111/j.1749-6632.2009.04416.x
173
WangP. K.CaoJ.WangH.LiangL.ZhangJ.LutzB. M.et al. (2015). Short-term sleep disturbance-induced stress does not affect basal pain perception, but does delay postsurgical pain recovery. J. Pain16, 1186–1199. 10.1016/j.jpain.2015.07.006pag
174
WeiH.HaoB.HuangJ. L.MaA. N.LiX. Y.WangY. X.et al. (2010). Intrathecal administration of a gap junction decoupler, an inhibitor of Na(+)-K(+)-2Cl(-) cotransporter 1, or a GABA(A) receptor agonist attenuates mechanical pain hypersensitivity induced by REM sleep deprivation in the rat. Pharmacol. Biochem. Behav.97, 377–383. 10.1016/j.pbb.2010.09.007
175
WeiH.MaA.WangY. X.PertovaaraA. (2008). Role of spinal 5-HT receptors in cutaneous hypersensitivity induced by REM sleep deprivation. Pharmacol. Res.57, 469–475. 10.1016/j.phrs.2008.05.007
176
WeiH.ZhaoW.WangY. X.PertovaaraA. (2007). Pain-related behavior following REM sleep deprivation in the rat: influence of peripheral nerve injury, spinal glutamatergic receptors and nitric oxide. Brain Res.1148, 105–112. 10.1016/j.brainres.2007.02.040
177
WodarskiR.Schuh-HoferS.YurekD.WaffordK.GilmourG.TreedeR. D.et al. (2015). Development and pharmacological characterization of a model of sleep disruption-induced hypersensitivity in the rat. Eur. J. Pain19, 554–566. 10.1002/ejp.580
178
YangH.De JongJ. W.CerniauskasI.PeckJ. R.LimB. K.GongH.et al. (2021). Pain modulates dopamine neurons via a spinal-parabrachial-mesencephalic circuit. Nat. Neurosci.24, 1402–1413. 10.1038/s41593-021-00903-8
179
YarnitskyD. (2010). Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr. Opin. Anaesthesiol.23, 611–615. 10.1097/ACO.0b013e32833c348b
180
YarnitskyD.BouhassiraD.DrewesA. M.FillingimR. B.GranotM.HanssonP.et al. (2015). Recommendations on practice of conditioned pain modulation (CPM) testing. Eur. J. Pain19, 805–806. 10.1002/ejp.605
181
YehudaS.SredniB.CarassoR. L.Kenigsbuch-SredniD. (2009). REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. J. Interferon Cytokine Res.29, 393–398. 10.1089/jir.2008.0080
182
ZielinskiM. R.KruegerJ. M. (2011). Sleep and innate immunity. Front. Biosci.3, 632–642. 10.2741/s176
Summary
Keywords
sleep deprivation, pain, nucleus accumbens, DNIC, NREMS, REMS, forced awakening, SWS
Citation
Kourbanova K, Alexandre C and Latremoliere A (2022) Effect of sleep loss on pain—New conceptual and mechanistic avenues. Front. Neurosci. 16:1009902. doi: 10.3389/fnins.2022.1009902
Received
02 August 2022
Accepted
29 November 2022
Published
20 December 2022
Volume
16 - 2022
Edited by
Luis de Lecea, Stanford University, United States
Reviewed by
Bradley Kerr, University of Alberta, Canada; Peter Drummond, Murdoch University, Australia; Brooke Schmeichel, East Tennessee State University, United States
Updates
Copyright
© 2022 Kourbanova, Alexandre and Latremoliere.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alban Latremoliere alatrem1@jhmi.eduChloe Alexandre calexa41@jhmi.edu
†These authors share senior authorship
This article was submitted to Sleep and Circadian Rhythms, a section of the journal Frontiers in Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.